/   Home   /   Newsroom   /   Research News

Researchers Identify Critical Role of Plk1 in Regulating Cancer Cell Cycle Progression and Metabolic Reprogramming

Dec 01, 2017     Email"> PrintText Size

A joint team of scientists, from University of Science and Technology of China and High Magnetic Field Laboratory, Chinese Academy of Sciences, identified that Polo-like kinase 1 (Plk1) plays a critical role for biosynthesis in cancer cells through activating pentose phosphate pathway (PPP).

Two hallmarks for cancer cells are the accelerated cell cycle progression as well as the altered metabolism, however, how these changes are coordinated to optimize the growth advantage for cancer cells are still poorly understood.

It has been established that Plk1 plays a critical role in various aspects of mitotic events, such as mitotic entry, centrosome maturation, and mitotic spindle assembly. Increasing evidence suggests that Plk1 is also involved in other cellular events in addition to mitosis.

While these significant observations accumulated over past years greatly extended the functions of Plk1 in facilitating human malignancies, up to date, there is no evidence to show that Plk1 is directly involved in biosynthesis or metabolic regulation.

Specifically, no metabolic enzymes have been identified so far as a direct target of Plk1, at least to the best of our knowledge.

The research team finds that Plk1 interacts with and directly phosphorylates glucose-6-phosphate dehydrogenase (G6PD), a rate-limiting enzyme of PPP.

By activating G6PD through promoting the formation of its active dimer, Plk1 increases PPP flux and directs glucose to the production of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) and ribose for the synthesis of macromolecules.

Importantly, they further demonstrate that Plk1-mediated activation of G6PD is indispensable for its role to promote cell cycle progression and cancer cell growth both in vitro and in vivo.

Collectively, these findings establish a critical role for Plk1 in regulating biosynthesis in cancer cells, exemplifying how cell cycle progression and metabolic reprogramming are coordinated for cancer progression.

 

Working model of Plk1 coordinates biosynthesis during cell cycle progression by directly activating PPP (Image by MA Xiaoyu) 

Attachment:

(Editor: ZHANG Nannan)

Contact

WANG Junfeng

High Magnetic Field Laboratory

Phone: 86-551-65591672
E-mail: junfeng@hmfl.ac.cn

Related Articles

β-carotene;Y.lipolytica;biosynthesis

Oleaginous Yeast Serves as β-carotene Cell Factory

Apr 20, 2017

Prof. YANG Sheng and colleagues at Shanghai Institute of Plant Physiology and Ecology of Chinese Academy of Sciences developed a series of genome editing tools for Y. lipolytica. And they generated an efficient biosynthetic pathway using strong promoters and multiple gene...

Secondary cell wall;repressor;regulatory pathway;biosynthesis;lodge resistance;rice

IGDB Scientists Found an Uncanonical CCCH-tandem Zinc Finger Protein Repressing Secondary Wall Synthesis in Rice

Nov 29, 2017

The group of Prof. ZHOU Yihua from the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, recently reported that an uncanonical CCCH-tandem zinc finger protein IIP4 negatively regulates secondary synthesis, its repressive effect is attenuated by...

Contact Us

Copyright © 2002 - 2017 Chinese Academy of Sciences